‘Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?’ A comparison between patients’ self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study
- 1 May 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (8) , 1075-1077
- https://doi.org/10.1097/00002030-200105250-00024
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAARTHIV Research & Clinical Practice, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Patient-Reported Nonadherence to HAART Is Related to Protease Inhibitor LevelsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Adherence to HIV combination therapySocial Science & Medicine, 2000
- Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationAIDS, 2000
- Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatmentAIDS, 2000
- Pharmacokinetic Interaction between Ritonavir and Indinavir in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 1998
- Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobioticsBiochemical Journal, 1992
- A behavioral medicine perspective on adherence to long-term medical regimens.Journal of Consulting and Clinical Psychology, 1982